Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... cells. Expression of the MAGE-A3 gene has been observed in testicular cells but without antigen presentation capabilities. MAGE-A3 ASCI is an investigational compound and it is not ...
2009 NOV 23 ... for many patients' deaths." CEL-SCI's L.E.A.P.S.™ (Ligand Epitope Antigen Presentation System) technology allows the Company to direct an immune response against specific ...
2009 NOV 23 ... from disease progression. Optimal T-cell reactivity to HIV-1 presumably requires antigen processing and presentation by professional antigen-presenting cells, particularly ...
2009 NOV 17 ... importantly, are able to both chemotactically recruit and activate dendritic antigen-presenting cells. These potetn immunostimulants, including defensins, cathelicidin ... at the Laboratory of Molecular Immunoregulation - NCI Frederick, is to give a keynote presentation on a group of structurally diverse multifunctional host proteins called "alarmins", at ...
2009 NOV 30 ... kinase/signal transducer and activator of transcription signaling pathway, in regulating antigen presentation by human DCs (hDC)." "We find that human SOCS1 (hSOCS1)-silenced DCs have ...
2009 NOV 30 ... these mice cannot present OVA to autoreactive T cells (OT-I cells), whereas the LCs are antigen presentation-competent. Unexpectedly, OT-I cell injection into diphtheria toxin (DT)-treated beta(2)m ...
2009 NOV 25 ... from the United States, "We aim to define the role of Kupffer cells in intrahepatic antigen presentation, using the selective delivery of antigen to Kupffer cells rather than other populations ...
2009 NOV 30 ... to a significant reduction in the expression level of the codelivered antigen in vivo. Antigen presentation by antigen-presenting cells was also reduced and resulted in the induction of weak ...
2009 NOV 16 ... complex (MHC) class I complexes are essential for optimal peptide loading and subsequent antigen presentation. MHC class I folding involves the coordinated formation of multiple disulfide bonds ...
2009 NOV 30 ... to transduce nondividing cells, including dendritic cells, enabling sustained endogenous antigen presentation and thus the induction of high proportions of specific cytotoxic T cells and ...
2009 NOV 24 ... mononuclear cells. Furthermore, DCs treated with EBER showed mature phenotype and antigen presentation capacity," wrote D. Iwakiri and colleagues, Hokkaido University. The ...
2009 NOV 17 ... containing a few eccrine ducts. These epithelial structures expressed carcinoembryonic antigen, cytokeratin 14, and cytokeratin 77, in a pattern suggesting ductal eccrine ... and colleagues published their study in American Journal of Dermatopathology (A Unique Presentation of Eccrine Hamartoma: Eccrine Nevus With Abnormal Eccrine Structures and Angiomyxoid ...
2009 NOV 27 ... "Together our findings demonstrate an important role for DPP9 in peptide turnover and antigen presentation."Geissfriedlander and colleagues published their study in the Journal of ...
2009 NOV 16 ... of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nature Immunology, 2009;10(10):1096-U73). For more information, contact ...
2009 NOV 30 ... "These results suggest that the G1896A pre-core mutation may directly interfere with antigen presentation, most likely by decreasing the availability of HLA class II molecules, and this may ...
2009 NOV 30 ... at 4 dpi. In the spleen, immune-related processes including NK cell cytotoxicity and antigen presentation were highly activated by 2 dpi. These differences are not attributable solely to ...
2009 NOV 30 ... cells (APCs) significantly decreased major histocompatibility complex (MHC) II antigen presentation and decreased synthesis of 13 chemokines and cytokines, suggesting a potent viral ...
2009 NOV 23 ... States, "Pathogen selection is postulated to drive MHC allelic diversity at loci for antigen presentation. However, readily apparent MHC infectious disease associations are rare in most ...
2009 NOV 16 ... MabThera is a therapeutic antibody that binds to a particular protein - the CD20 antigen - on the surface of normal and malignant B-cells. It then recruits the body's natural ... it usually develops slowly.2 Data from the trial will be submitted for presentation at an upcoming international medical meeting and will be filed with EU and US health ...
